Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - clomipramine hydrochloride - unknown - clomipramine hydrochloride azepine active 0.0 - active constituent

Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra veterinary products (australia) pty. ltd. - clomipramine hydrochloride - unknown - clomipramine hydrochloride azepine active 0.0 - active constituent

Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

mavlab pty. ltd. - clomipramine hydrochloride - unknown - clomipramine hydrochloride azepine active 0.0 - active constituent

Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra veterinary products (australia) pty. ltd. - clomipramine hydrochloride - unknown - clomipramine hydrochloride azepine active 0.0 - active constituent

Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kato laboratories pty ltd - clomipramine hydrochloride - unknown - clomipramine hydrochloride azepine active 0.0 - active constituent

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

actavis pharma, inc. - methylphenidate hydrochloride (unii: 4b3sc438hi) (methylphenidate - unii:207zz9qz49) - methylphenidate hydrochloride 5 mg - attention deficit disorders (previously known as minimal brain dysfunction in children). other terms being used to describe the behavioral syndrome below include: hyperkinetic child syndrome, minimal brain damage, minimal cerebral dysfunction, minor cerebral dysfunction. methylphenidate hydrochloride is indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. the diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. nonlocalizing (soft) neurological signs, learning disability, and abnormal eeg may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted. speci

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

breckenridge pharmaceutical, inc. - methylphenidate hydrochloride (unii: 4b3sc438hi) (methylphenidate - unii:207zz9qz49) - methylphenidate hydrochloride 5 mg in 5 ml - attention deficit disorders (previously known as minimal brain dysfunction in children). other terms being used to describe the behavioral syndrome below include: hyperkinetic child syndrome, minimal brain damage, minimal cerebral dysfunction, minor cerebral dysfunction. methylphenidate hydrochloride oral solution is indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. the diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. nonlocalizing (soft) neurological signs, learning disability, and abnormal eeg may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be wa

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

apotex nz ltd - clomipramine hydrochloride 10mg;  ;   - film coated tablet - 10 mg - active: clomipramine hydrochloride 10mg     excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium hypromellose iron oxide yellow lactose monohydrate macrogol 3350 magnesium stearate microcrystalline cellulose purified water titanium dioxide - the treatment of depressive states (in adults only) including endogenous, reactive, neurotic, organic, masked and involutional forms of depression, depression associated with schizophrenia and personality disorders, depressive syndromes due to presenility or senility, chronic painful conditions, and chronic somatic diseases, and depressive mood disorders of a reactive, neurotic or psychopathic nature. chronic painful conditions

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

apotex nz ltd - clomipramine hydrochloride 25mg;  ;   - film coated tablet - 25 mg - active: clomipramine hydrochloride 25mg     excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium hypromellose iron oxide yellow lactose monohydrate macrogol 3350 magnesium stearate microcrystalline cellulose purified water titanium dioxide - the treatment of depressive states (in adults only) including endogenous, reactive, neurotic, organic, masked and involutional forms of depression, depression associated with schizophrenia and personality disorders, depressive syndromes due to presenility or senility, chronic painful conditions, and chronic somatic diseases, and depressive mood disorders of a reactive, neurotic or psychopathic nature. chronic painful conditions

Malta - angļu - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - clomipramine hydrochloride - hard capsule - clomipramine hydrochloride 10 mg - psychoanaleptics